Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6930-6936

  Hofmann, Christian ^a,g   Löser, Peter ^a   Cichon, Günter ^b   Arnold, Wolfgang ^a,c   Both, Gerald W ^d   Strauss, Michael ^a,e,f  

^a HepaVec AG für Gentherapie   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c Biomedizinischer Forschungscampus B   (Germany)

^d CSIRO   (Australia)

^e HUMBOLDT UNIVERSITY   (Germany)

^f DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^g HepaVec GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; COMPLEMENTARY DNA; NEUTRALIZING ANTIBODY; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; GENE TRANSFER; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION; VIRUS RECOMBINANT;

EID: 0344780779     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6930-6936.1999     Document Type: Article

References (57)

1. Barr, D., J. Tubb, A. Scaria, A. Lieber, C. Wilson, J. Perkins, and M. A. Kay. 1995. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:151-155.
2. Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
3. Boulikas, T. 1998. Status of gene therapy in 1997: molecular mechanisms, disease targets, and clinical applications. Gene Ther. Mol. Biol. 1:1-172.
4. Boyle, D. B., A. D. Pye, R. Kocherhans, B. M. Adair, S. Vrati, and G. W. Both. 1994. Characterisation of Australian ovine adenovirus isolates. Vet. Microbiol. 41:281-291.
5. Bramson, J. L., M. Hitt, J. Gauldie, and F. L. Graham. 1997. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination. Gene Ther. 4:1069-1076.
6. Chartier, C., E. Degryse, M. Gantzer, A. Dieterle, A. Pavirani, and M. Methali. 1996. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70:4805-4810.
7. Cichon, G., and M. Strauss. 1998. Transient immunosuppression with 15-deoxyspergualin prolongs reporter gene expression and reduces humoral immune response after adenoviral gene transfer. Gene Ther. 5:85-90.
8. Croyle, M. A., M. Stone, G. L. Amidon, and B. J. Roessler. 1998. In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine. Gene Ther. 5:645-654.
9. Crystal, R. G. 1995. Transfer of genes to humans: early lessons and obstacles to success. Science 270:404-410.
10. Grubb, R., R. J. Pickles, H. Ye, J. R. Yankaskas, R. N. Vick, J. F. Engelhardt, J. M. Wilson, L. G. Johnson, and R. C. Boucher. 1994. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371:802-806.
11. Guibinga, G.-H., H. Lochmuller, B. Massie, J. Nalbantoglu, G. Karpati, and B. J. Petrof. 1998. Combinatorial blockade of calcineurin and CD28 signaling facilitates primary and secondary therapeutic gene transfer by adenovirus vectors in dystrophic (mdx) mouse muscles. J. Virol. 72:4601-4609.
12. Harrach, B., B. M. Meehan, M. Benkö, B. M. Adair, and D. Todd. 1997 Close phylogenetic relationship between egg drop syndrome virus, bovine adenovirus serotype 7, and ovine adenovirus strain 287. Virology 229:302-306.
13. Horwitz, M. S. 1990. Adenoviruses and their replication, p. 1679-1722. In B. N. Fields and D. M. Knipe (ed.), Fields virology. Raven Press, New York, N.Y.
14. Horwitz, M. S. 1990. Adenoviruses, p. 1723-1740. In B. N. Fields and D. M. Knipe (ed.), Fields virology. Raven Press, New York, N.Y.
15. Huebner, J. R., W. P. Rowe, T. G. Ward, R. H. Parrott, and J. A. Bell. 1954. Adenoidal-pharyngeal conjunctival agents. N. Engl. J. Med. 251:1077-1086.
16. Ilan, Y., B. Sauter, N. Roy Chowdhury, B. V. N. Reddy, N. R. Thummala, G. Droguelt, A. Davidson, M. Ott, M. S. Horwitz, and J. Roy Chowdhury. 1998. Oral tolerization to adenoviral proteins permits repeated adenovirus-medi-ated gene therapy in rats with pre-existing immunity to adenoviruses. Hepatology 27:1368-1376.
17. Kagami, H., J. C. Atkinson, S. M. Michalek, B. Handelman, S. Yu, B. J. Baum, and B. O'Connell. 1998. Repetitive adenovirus administration to the parotid gland: role of immunological barriers and induction of oral tolerance. Hum. Gene Ther. 9:305-313.
18. Kay, M. A., A. X. Holterman, L. Meuse, A. Gown, H. D. Ochs, P. S. Linsley, and C. B. Wilson. 1995. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat. Genet. 11:191-197.
19. Kay, M. A., L. Meuse, A. M. Gown, P. Linsley, D. Hollenbaugh, A. Aruffo, H. D. Ochs, and C. B. Wilson. 1997. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver. Proc. Natl. Acad. Sci. USA 94:4686-4691.
20. Khatri, A., and G. W. Both. 1998. Identification of transcripts and promoter regions of ovine adenovirus OAV287. Virology 245:128-141.
21. Khatri, A., Z. Z. Xu, and G. W. Both. 1997. Gene expression by atypical recombinant ovine adenovirus vectors during abortive infection of human and animal cells in vitro. Virology 239:226-237.
22. Klonjkowski, B., P. Gilardi-Hebenstreit, J. Hadchouel, V. Randrianarlson, S. Boutin, P. Yeb, M. Perricaudet, and E. J. Kremer. 1997. A recombinant El-deleted canine adenoviral vector capable of transduction and expression of a transgene in human-derived cells and in vivo. Hum. Gene Ther. 8:2103-2115.
23. Kozarsky, K. F., D. R. McKinley, L. L. Austin, S. E. Raper, L. D. Stratford Perricaudel, and J. M. Wilson. 1994. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269:13695-13702.
24. Kremer, E. J., and M. Perricaudet. 1995. Adenovirus and adeno-associated virus-mediated gene transfer. Br. Med. Bull. 51:31-46.
25. Li, Z., A. Rakkar, Y. Katayose, M. Kim, N. Shanmugam, S. Srivastava, J. W. Moul, D. G. McLeod, K. H. Cowan, and P. Seth. 1998. Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model. Gene Ther. 5:605-613.
26. Mack, C. A., W. R. Song, H. Carpenter, T. J. Wickham, I. Kovesdi, B. G. Harvey, C. J. Magovern, O. W. Isom, T. Rosengart, E. Falck-Pedersen, N. R. Hackett, R. G. Crystal, and A. Mastrangeli. 1997. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. Hum. Gene Ther. 8:99-109.
27. Maizel, J. V., D. O. White, and M. D. Scharff. 1968. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 36:115-125.
28. Mastrangeli, A., B. G. Harvey, J. Yao, G. Wolff, I. Kovesdi, R. G. Crystal, and E. Falck-Pedersen. 1996. "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus sero-type. Hum. Gene Ther. 7:79-87.
29. McClane, S. J., N. Chirmule, C. V. Burke, and S. E. Raper. 1997. Characterization of the immune response after local delivery of recombinant adenovirus in murine pancreas and successful strategies for readministration. Hum. Gene Ther. 8:2207-2216.
30. Morral, N., W. O'Neal, H. Zhou, C. Langsten, and A. Beaudet. 1997. Immune response to reporter proteins and high level dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors. Hum. Gene Ther. 8:1275-1286.
31. 1-antitrypsin after systemic delivery. Hum. Gene Ther. 9:1587-1598.
32. Paillard, F. 1997. Advantages of non-human adenoviruses versus human adenoviruses. Hum. Gene Ther. 8:2007-2010.
33. Pye, D. 1989. Cell lines for growth of sheep viruses. Austr. Vet. J. 66:231-232.
34. Rawle, F. C., B. B. Knowles, R. P. Ricciardi, V. Brahmacheri, P. Duerksen-Hughes, W. S. Wold, and L. R. Gooding. 1991. Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. J. Immunol. 144:3977-3984.
35. Roy, S., P. S. Shirley, A. McClelland, and M. Kaleko. 1998. Circumvention of immunity to the adenovirus major coat protein hexon. J. Virol. 72:6875-6879.
36. Sandig, V., P. Läser, A. Lieber, M. A. Kay, and M. Strauss. 1996. HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene. Gene Ther. 3:1002-1009.
37. INK4/CDKN2and p53 genes cooperate to induce apoptotic tumor cell death. Nat. Med. 3:313-319.
38. Schiedner, G., N. Morral, R. J. Parks, Y. Wu, S. C. Koopmans, C. Langsten, F. L. Graham, A. L. Beaudet, and S. Kochanek. 1998. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18:180-183.
39. Smith, T. A., M. G. Mehaffey, D. B. Kayda, J. M. Saunders, S. Yei, B. C. Trapnell, A. McClelland, and M. Kaleko. 1993. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat. Genet. 5:397-402.
40. Smith, T. A., B. D. White, J. M. Gardner, M. Kaleko, and A. McClelland. 1996. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. Gene Ther. 3:496-502.
41. Song, W.-R., H. L. Kong, P. Traktman, and R. G. Crystal. 1997. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenovirus. Hum. Gene Ther. 8:1207-1217.
42. Suzuki, M., R. Singh, M. A. S. Moon, W.-R. Song, and R. G. Crystal. 1998. Similarity of strain- and route-dependent murine responses to an adenovirus vector using homologous thrombopoietin cDNA as the reporter genes. Hum. Gene Ther. 9:1223-1231.
43. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545-550.
44. Van Ginkel, F. W., C. Liu, J. W. Simecka, J.-Y. Dong, T. Greenway, R. A. Frizzell, H. Kiyono, J. R. McGhee, and D. W. Pascual. 1995. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and beta-galactosidase. Hum. Gene Ther. 6:895-903.
45. Venktesh, A., F. Watt, Z. Z. Xu, and G. W. Both. 1998. Ovine adenovirus (OAV287) lacks a virus-associated RNA gene. J. Gen. Virol. 79:509-516.
46. Vrancken-Peeters, M. J., G. A. Patijn, A. Lieber, L. Meuse, and M. A. Kay. 1996. Adenovirus-mediated hepatic gene transfer in mice: comparison of intravascular and biliary administration. Hum. Gene Ther. 7:1693-1699.
47. Vrati, S., D. B. Boyle, R. Kockerhans, and G. W. Both. 1995. Sequence of ovine adenovirus 100k hexon assembly, 33k, pVIII and fiber genes: early region E3 is not in the expected location. Virology 209:400-406.
48. Vrati, S., D. E. Brookes, D. B. Boyle, and G. W. Both. 1995. Nucleotide sequence of ovine adenovirus tripartite leader sequence and homologues of Iva2, DNA polymerase and terminal proteins. Gene 177:35-41.
49. Vrati, S., P. S. Brookes, A. Khatri, D. B. Boyle, and G. W. Both. 1995. Unique genome arrangement of an ovine adenovirus: identification of new proteins and proteinase cleavage sites. Virology 220:186-199.
50. Vrati, S., E. S. Macavoy, Z. Z. Xu, C. Smole, D. B. Boyle, and G. W. Both. 1996. Construction and transfection of ovine adenovirus genomic clones to rescue modified viruses. Virology 220:200-203.
51. Welsh, J., A. E. Smith, J. Zabner, D. P. Rich, S. M. Graham, R. J. Gregory, B. M. Pratt, and R. A. Moscicki. 1994. Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium. Hum. Gene Ther. 5:209-219.
52. Wohlfart, C. 1988. Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms. J. Virol. 62:2321-2328.
53. Xu, Z. Z., and G. W. Both. 1998. Altered tropism of an ovine adenovirus carrying the fiber protein cell binding domain of human adenovirus type 5. Virology 248:156-163.
54. Xu, Z. Z., A. Hyatt, D. B. Boyle, and G. W. Both. 1997. Construction of ovine adenovirus recombinants by gene insertion or deletion of related terminal region sequences. Virology 230:62-71.
55. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc. Nail. Acad. Sci. USA 91:4407-4411.
56. Yang, Y., Q. Su, I. S. Grewal, R. Schilz, R A. Flavell, and J. M. Wilson. 1996. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J. Virol. 70:6370-6377.
57. Zabner, J., L. A. Couture, R. J. Gregory, S. M. Graham, A. E. Smith, and M. J. Welsh. 1993. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75:207-216.